Diverticular Disease and Rifaximin: An Evidence-Based Review

Diverticular Disease and Rifaximin: An Evidence-Based Review

There have been considerable advances in the treatment of diverticular disease in recent years. Antibiotics are frequently used to treat symptoms and prevent complications. Rifaximin, a non-absorbable antibiotic, is a common therapeutic choice for symptomatic diverticular disease in various countrie...

Full description

Bibliographic Details
Main Authors: Anna Piccin, Marco Gulotta, Stefano di Bella, Paola Martingano, Lory Saveria Crocè, Mauro Giuffrè
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Antibiotics
Subjects:
diverticulosis
diverticular disease
acute diverticulitis
rifaximin
fiber supplementation
microbiota
Online Access:https://www.mdpi.com/2079-6382/12/3/443

Internet

https://www.mdpi.com/2079-6382/12/3/443

Similar Items